Notably, cloud was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead of Covid-19 and internet of things, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Pfizer had the greatest increase in references for cloud in Q1 2023, compared with the previous quarter. GlobalData identified 2 cloud-related sentences in the company’s filings – 4% of all sentences – and an increase of 100% in Q1 2023 compared with Q1 2022. Sanofi’s mentions of cloud rose by 100% to 1.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cloud in Q1 2023 was 62.
To further understand GlobalData’s analysis on Cloud Computing in Healthcare – Thematic Intelligence, buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.
Source link
#Mentions #cloud #increased #pharmaceutical #industry
